Companies / Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc.

NYSE: DNACIK 1830214BOSTON, MAginkgo.bio

Financials · FY2025

Revenue$170.16M
Net income$-312.76M
Total debt
Cash$84.53M
Diluted EPS$-5.64
Shares outstanding67.3M

Ownership

67.3M shares outstanding · as of Jul 31, 2026
0.01%Insiders
Ownership
82.2%Class A
Share classes
Class A82.24%
Class B13.30%
Common Stock4.46%
Insiders0.01%9,099
10%+ / strategic3.55%2,391,649
Institutions45.41%30,577,242
Public float51.03%34,362,287

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Coen Steven P.See remarks
0.01%9,099
Sloan HarryDirector

Institutional holders 182

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
Add$7.03M+710K
+19.86%
4,282,903
6.36% of shares
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
Trim$-3.87M-466K
-43.61%
602,576
0.89% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
Add$2.69M+439K
+897.85%
487,957
0.72% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
Add$1.79M+180K
+13.95%
1,472,370
2.19% of shares
low
Q4 2025
as of
Peak6 LLC
13F manager
New$1.35M+163K
162,837
0.24% of shares
low
Q1 2026
as of
Glenview Capital Management, LLC
13F manager
Exit$-1.24M-149K
-100.00%
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
Add$761.5K+124K
+72.84%
294,788
0.44% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
New$615.8K+100K
100,456
0.15% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
BAILLIE GIFFORD & COPassive13G/A2,391,649
Viking Global Investors LPPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DNA37611X209